Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

Affiliations

¹ Department of Hematology and Oncology, University of Magdeburg, Magdeburg, Germany.
² University Hospital Leipzig, 04106, Leipzig, Germany.
³ Department of Hematology and Oncology, Hospital Magdeburg, Magdeburg, Germany.
⁴ Klinik fur Innere Medizin II, Universitatsklinikum Jena, Jena, Germany.
⁵ Department of Hematology and Oncology, University Hospital, Halle, Germany.
⁶ Department of Hematology and Oncology, Klinikum Schwerin, Schwerin, Germany.
⁷ Departement of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
⁸ Medizinische Klinik, Carl-Thieme-Klinikum GmbH, Cottbus, Germany.
⁹ Department of Hematology and Oncology, Helios Klinikum Erfurt, Erfurt, Germany.
¹⁰ Klinikum Dessau, Dessau, Germany.
¹¹ Klinikum, Zittau, Germany.
¹² Department of Medicine I, Wilhelminen Cancer Research Institute, WilhelminenhospitalVienna, Austria.
¹³ Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany.
¹⁴ Department of Hematology, Oncology and Palliative Care, Ernst Von Bergmann Hospital, Potsdam, Germany.
¹⁵ Hematology and Oncology, University of Greifswald, Greifswald, Germany.
¹⁶ University Hospital Leipzig, 04106, Leipzig, Germany. dietger.niederwieser@medizin.uni-leipzig.de.
¹⁷ Lithuanian University of Health Sciences, Kaunas, Lithuania. dietger.niederwieser@medizin.uni-leipzig.de.
¹⁸ Aichi Medical University, Nagakute, Japan. dietger.niederwieser@medizin.uni-leipzig.de.

Published Erratum

Thomas Heinicke et al. Ann Hematol. 2021 Nov.

. 2021 Nov;100(11):2877-2878.

doi: 10.1007/s00277-021-04638-1.

¹ Department of Hematology and Oncology, University of Magdeburg, Magdeburg, Germany.
² University Hospital Leipzig, 04106, Leipzig, Germany.
³ Department of Hematology and Oncology, Hospital Magdeburg, Magdeburg, Germany.
⁴ Klinik fur Innere Medizin II, Universitatsklinikum Jena, Jena, Germany.
⁵ Department of Hematology and Oncology, University Hospital, Halle, Germany.
⁶ Department of Hematology and Oncology, Klinikum Schwerin, Schwerin, Germany.
⁷ Departement of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
⁸ Medizinische Klinik, Carl-Thieme-Klinikum GmbH, Cottbus, Germany.
⁹ Department of Hematology and Oncology, Helios Klinikum Erfurt, Erfurt, Germany.
¹⁰ Klinikum Dessau, Dessau, Germany.
¹¹ Klinikum, Zittau, Germany.
¹² Department of Medicine I, Wilhelminen Cancer Research Institute, WilhelminenhospitalVienna, Austria.
¹³ Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany.
¹⁴ Department of Hematology, Oncology and Palliative Care, Ernst Von Bergmann Hospital, Potsdam, Germany.
¹⁵ Hematology and Oncology, University of Greifswald, Greifswald, Germany.
¹⁶ University Hospital Leipzig, 04106, Leipzig, Germany. dietger.niederwieser@medizin.uni-leipzig.de.
¹⁷ Lithuanian University of Health Sciences, Kaunas, Lithuania. dietger.niederwieser@medizin.uni-leipzig.de.
¹⁸ Aichi Medical University, Nagakute, Japan. dietger.niederwieser@medizin.uni-leipzig.de.

No abstract available

Figures

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Heinicke T, Krahl R, Kahl C, Cross M, Scholl S, Wolf HH, Hähling D, Hegenbart U, Peter N, Schulze A, Florschütz A, Schmidt V, Reifenrath K, Zojer N, Junghanss C, Sayer HG, Maschmeyer G, Späth C, Hochhaus A, Fischer T, Al-Ali HK, Niederwieser D. Heinicke T, et al. Ann Hematol. 2021 Sep;100(9):2387-2398. doi: 10.1007/s00277-021-04565-1. Epub 2021 Jul 7. Ann Hematol. 2021. PMID: 34232360 Free PMC article. Clinical Trial.